<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04690634</url>
  </required_header>
  <id_info>
    <org_study_id>PCOS DEXA</org_study_id>
    <nct_id>NCT04690634</nct_id>
  </id_info>
  <brief_title>The Changes of Body Fat Distribution in Obese Patients With PCOS After LSG</brief_title>
  <official_title>The Changes of Body Fat Distribution in Obese Patients With Polycystic Ovary Syndrome After Laparoscopic Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with a prevalence of 5% to&#xD;
      15% in premenopausal women. Patients with PCOS presents as abnormal menstruation, ovulation&#xD;
      disorders and/or hyperandrogenemia, and often accompanied by insulin resistance and other&#xD;
      metabolic abnormalities. Abdominal fat accumulation, overweightness and obesity are&#xD;
      frequently present in patients with PCOS . Visceral adipose tissue (VAT) plays an important&#xD;
      role in the pathogenesis of PCOS.Therefore，this study aim to investigate the changes of body&#xD;
      fat distribution in obese women with PCOS after laparoscopic sleeve gastrectomy (LSG), and to&#xD;
      explore the factors that may predict the changes in body fat distribution in PCOS patients&#xD;
      after LSG.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body fat distribution</measure>
    <time_frame>12 months</time_frame>
    <description>The fat mass was measured in different regions including arms, legs, trunk, head, android , gynoid and Visceral fat regions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>12 months</time_frame>
    <description>body mass index (kg/m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>12 months</time_frame>
    <description>waist circumference (cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>12 months</time_frame>
    <description>Hip circumference (cm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sex hormones</measure>
    <time_frame>12 months</time_frame>
    <description>total testosterone (nmol/L), testosterone (nmol/L) and SHBG (nmol/L).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolic profiles</measure>
    <time_frame>12 months</time_frame>
    <description>fasting glucose（mmol/L), Total cholesterol (mmol/L)(mmol/L),Triglycerides (mmol/L),HDL-c (mmol/L), LDL-c (mmol/L),</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">153</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>PCOS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>obese female patients with Polycystic ovary syndrome. All participants underwent laparoscopic sleeve gastrectomy (LSG)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>obese female patients without Polycystic ovary syndrome. All participants underwent laparoscopic sleeve gastrectomy (LSG)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic sleeve gastrectomy (LSG)</intervention_name>
    <description>Multiple studies have indicated that laparoscopic sleeve gastrectomy (LSG) was superior to nonsurgical approaches for the treatment of obese PCOS patients over both the short and long term</description>
    <arm_group_label>PCOS group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Fmale aged 18- 45;&#xD;
&#xD;
          2. Meet Rotterdam criteria(2003);&#xD;
&#xD;
          3. body mass index (BMI)≥30 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Gender is male;&#xD;
&#xD;
          2. Younger than 18 years old or older than 45 years old ;&#xD;
&#xD;
          3. secondary obesity due to endocrine disorders;&#xD;
&#xD;
          4. history of malignant tumors; 5）sever hepatic and renal disease;&#xD;
&#xD;
        6) concurrent participation in other clinical trials; 7) sever endocrine and hereditary&#xD;
        diseases; 8) mental illnesses that rendered them unable to provide informed consent; 9)&#xD;
        patients declining to undergo complete study testing.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shen Qu, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Shang hai Tenth People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Endocrinology, Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200070</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>December 27, 2020</last_update_submitted>
  <last_update_submitted_qc>December 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Zhang Manna</investigator_full_name>
    <investigator_title>Director, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic Sleeve Gastrectomy</keyword>
  <keyword>Body fat distribution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

